Main Street Research LLC Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Main Street Research LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 79,531 shares of the medical equipment provider’s stock after acquiring an additional 1,482 shares during the quarter. Intuitive Surgical makes up about 2.6% of Main Street Research LLC’s holdings, making the stock its 15th biggest holding. Main Street Research LLC’s holdings in Intuitive Surgical were worth $41,512,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Massachusetts Financial Services Co. MA acquired a new position in Intuitive Surgical in the third quarter valued at $558,807,000. Proficio Capital Partners LLC lifted its holdings in shares of Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares during the last quarter. FMR LLC boosted its position in shares of Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the period. Raymond James Financial Inc. purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $313,769,000. Finally, Wilmington Savings Fund Society FSB increased its position in Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after buying an additional 552,058 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

ISRG opened at $518.26 on Monday. The company has a market cap of $184.59 billion, a price-to-earnings ratio of 80.85, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The business’s fifty day moving average is $571.36 and its two-hundred day moving average is $531.85.

Analysts Set New Price Targets

ISRG has been the topic of a number of research reports. Raymond James raised their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. UBS Group lifted their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Piper Sandler restated an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Finally, Citigroup upped their price objective on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,579 shares of company stock worth $7,756,844 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.